Structure solved at Scripps shows how one human protein reduces potency of chemotherapy

ested in clinical trials as an adjuvant for chemotherapy. The idea is that these inhibitors could be administered at the same time as chemotherapy to make chemotherapy more effective.

"Having the structure solved allows us to make [inhibitors] that are [even] more selective," Pegg says.

The structure also provides a way of designing proteins to improve cancer treatments, says Tainer. The molecular details of the structure show how AGT could be modified to resist selective inhibitors. This could be used to protect critical tissues from the chemotherapy even when administered at high doses. For example, a cancer patient taking chemotherapy and AGT inhibitors could at the same time receive an infusion of modified bone marrow cells that would have a form of AGT protein able to resist the inhibitors, which could protect the patient from some of chemotherapy's more toxic side effects.

Daniels and Tainer had already solved the free-form structure of AGT (not bound to DNA), and when they compared this to the DNA-bound form, they found that the structures were identical. The fact that AGT's structure does not change after binding the DNA suggests a simple one-step pathway whereby AGT repairs damaged DNA.

The model that Daniels, Tainer, Pegg, and their colleagues are suggesting is one of twist and grab.

AGT recognizes a piece of DNA that is damaged and binds to that DNA. Then it twists out the phosphate backbone of the DNA, exposing the damaged base, repairs the base by grabbing the offending alkyl group and transferring it onto itself, and releases the now repaired section of DNA. In doing so, the protein is used up.

DNA commonly twists in such a way that there is a major groove (like the part of the staircase with the steps) and a minor groove (like the part with the rail). One of the details that has emerged from this study is that AGT recognizes the minor groove of DNA.

Most proteins that bind to DNA bind in

Contact: Jason Bardi
Scripps Research Institute

Page: 1 2 3 4

Related biology news :

1. Structure solved by Scripps scientists shows one way that body controls gene expression
2. Structure of a Nobel-prize winning molecule: Aquaporin
3. Structure of HIV-neutralizing antibody solved
4. Structure of key breast cancer receptor determined
5. Structure of cog at the hub of metabolism reveals anti-ageing function
6. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
7. Structure reveals details of cells cargo-carriers
8. Structure of key receptor unlocked; Related proteins will fall like dominoes
9. New Science Press launches Proteins: From Sequence to Structure
10. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
11. Structure of key protein involved in cancer, osteoporosis and foot-and-mouth disease finally solved

Post Your Comments:

(Date:1/23/2020)... ... 23, 2020 , ... GIOSTAR/HEAMGEN has developed and ... The red blood cells are made utilizing a bioreactor that permits the ... and replaces the need for a human blood donor. GIOSTAR/HEAMGEN mature ...
(Date:1/22/2020)... ... January 21, 2020 , ... Astro Pak’s president Ken Carroll ... Department. The move, which is part of the company’s structural reorganization, was announced ... Senior Vice President where he oversaw its Cleanroom Division as well as both ...
(Date:1/10/2020)... , ... January 09, 2020 , ... ... bioactive spinal solutions, today announced the 510(K) clearance and commercial launch of the ... interbody fusion system. , The EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... BOSTON (PRWEB) , ... February ... ... privately-owned company) is pleased to announce the successful results from a long-term ... stenosis using the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block ...
(Date:2/10/2020)... , ... February 10, 2020 , ... R3 Medical Training ... March 13-14th, 2020 in Las Vegas. The course is hands on involving real ... For the past few years, the Comprehensive Stem Cell Training Course has received rave ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , ... The National Organization for Rare Disorders (NORD), to raise awareness amongst the general public ... The Balancing Act’s “Behind The Mystery” rare disease series will be ...
(Date:2/3/2020)... , ... February 03, 2020 , ... ... in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to ... is a best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping ...
Breaking Biology Technology:
Cached News: